Jennifer M Giltnane
8PUBLICATIONS
80CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 31, 2026
Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2- locally-advanced or metastatic breast cancer.Jackson Liang, Christy Ong, Kareem Heslop
|Dec 03, 2025
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations.Tianshi Lu, Habib Hamidi, Mark A Socinski
|Aug 29, 2025
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysis.Xiao Li, Ximo Pechuan-Jorge, Tyler Risom
|Mar 25, 2024
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy.Xiao Li, Jeffrey Eastham, Jennifer M Giltnane
|Jun 01, 2023
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.Sarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo
|Sep 21, 2022
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer.Jackson Liang, Ellen Rei Ingalla, Xiaosai Yao
Pageof 2
Frequent Collaborators
2 joint publications
Jackson Liang
2 joint publications
Barzin Y Nabet
2 joint publications
Sarat Chandarlapaty
2 joint publications
Heather M Moore
2 joint publications
Ching-Wei Chang
2 joint publications
Ciara Metcalfe
1 joint publications
M C Kelley
1 joint publications
Ellen Rei Ingalla
1 joint publications
Bu-Er Wang
1 joint publications
Lisa Tai
